Associated Factors of Atrophic Gastritis Diagnosed by Double-Contrast Upper Gastrointestinal Barium X-Ray Radiography: A Cross-Sectional Study Analyzing 6,901 Healthy Subjects in Japan
Double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It has been executed to find gastric cancer, but has not been usually executed to detect premalignant atrophic mucosa of stomach. To understand the meaning o...
Saved in:
| Published in | PloS one Vol. 9; no. 10; p. e111359 |
|---|---|
| Main Authors | , , , , , , , , , , , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
24.10.2014
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1932-6203 1932-6203 |
| DOI | 10.1371/journal.pone.0111359 |
Cover
Loading…
| Abstract | Double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It has been executed to find gastric cancer, but has not been usually executed to detect premalignant atrophic mucosa of stomach. To understand the meaning of UGI-XR-based atrophic gastritis, we analyzed its association with several causative factors including Helicobacter pylori (HP) infection.
We evaluated 6,901 healthy adults in Japan. UGI-XR-based atrophic gastritis was diagnosed based on the irregular shape of areae gastricae and its expansion in the stomach.
Of the 6,433 subjects with no history of HP eradication and free from gastric acid suppressants, 1,936 were diagnosed as UGI-XR-based atrophic gastritis (mild: 234, moderate: 822, severe: 880). These were univariately associated with serum HP IgG and serum pepsinogen I/II ratio with statistical significance. The multiple logistic analysis calculating standardized coefficients (β) and odds ratio (OR) demonstrated that serum HP IgG (β = 1.499, OR = 4.48), current smoking (β = 0.526, OR = 1.69), age (β = 0.401, OR = 1.49), low serum pepsinogen I/II ratio (β = 0.339, OR = 1.40), and male gender (β = 0.306, OR = 1.36) showed significant positive association with UGI-XR-based atrophic gastritis whereas drinking and body mass index did not. Among the age/sex/smoking/drinking-matched 227 pairs derived from chronically HP-infected and successfully HP-eradicated subjects, UGI-XR-based atrophic gastritis was detected in 99.1% of the former but in only 59.5% of the latter subjects (p<0.0001). Contrastively, UGI-XR-based atrophic gastritis was detected in 13 of 14 HP-positive proton pump inhibitor users (92.9%) and 33 of 34 HP-positive histamine H2-receptor antagonist users (97.1%), which are not significantly different from gastric acid suppressant-free subjects.
The presence of UGI-XR-based atrophic gastritis is positively associated with Helicobacter pylori infection, current smoking, age, decreased serum pepsinogen I/II ratio, and male gender. Eradication of Helicobacter pylori seems to superficially improve UGI-XR-based atrophic gastritis whereas intake of gastric acid suppressants does not. |
|---|---|
| AbstractList | Double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It has been executed to find gastric cancer, but has not been usually executed to detect premalignant atrophic mucosa of stomach. To understand the meaning of UGI-XR-based atrophic gastritis, we analyzed its association with several causative factors including Helicobacter pylori (HP) infection. We evaluated 6,901 healthy adults in Japan. UGI-XR-based atrophic gastritis was diagnosed based on the irregular shape of areae gastricae and its expansion in the stomach. Of the 6,433 subjects with no history of HP eradication and free from gastric acid suppressants, 1,936 were diagnosed as UGI-XR-based atrophic gastritis (mild: 234, moderate: 822, severe: 880). These were univariately associated with serum HP IgG and serum pepsinogen I/II ratio with statistical significance. The multiple logistic analysis calculating standardized coefficients ([beta]) and odds ratio (OR) demonstrated that serum HP IgG ([beta] = 1.499, OR = 4.48), current smoking ([beta] = 0.526, OR = 1.69), age ([beta] = 0.401, OR = 1.49), low serum pepsinogen I/II ratio ([beta] = 0.339, OR = 1.40), and male gender ([beta] = 0.306, OR = 1.36) showed significant positive association with UGI-XR-based atrophic gastritis whereas drinking and body mass index did not. Among the age/sex/smoking/drinking-matched 227 pairs derived from chronically HP-infected and successfully HP-eradicated subjects, UGI-XR-based atrophic gastritis was detected in 99.1% of the former but in only 59.5% of the latter subjects (p<0.0001). Contrastively, UGI-XR-based atrophic gastritis was detected in 13 of 14 HP-positive proton pump inhibitor users (92.9%) and 33 of 34 HP-positive histamine H.sub.2 -receptor antagonist users (97.1%), which are not significantly different from gastric acid suppressant-free subjects. The presence of UGI-XR-based atrophic gastritis is positively associated with Helicobacter pylori infection, current smoking, age, decreased serum pepsinogen I/II ratio, and male gender. Eradication of Helicobacter pylori seems to superficially improve UGI-XR-based atrophic gastritis whereas intake of gastric acid suppressants does not. Double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It has been executed to find gastric cancer, but has not been usually executed to detect premalignant atrophic mucosa of stomach. To understand the meaning of UGI-XR-based atrophic gastritis, we analyzed its association with several causative factors including Helicobacter pylori (HP) infection.BACKGROUNDDouble-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It has been executed to find gastric cancer, but has not been usually executed to detect premalignant atrophic mucosa of stomach. To understand the meaning of UGI-XR-based atrophic gastritis, we analyzed its association with several causative factors including Helicobacter pylori (HP) infection.We evaluated 6,901 healthy adults in Japan. UGI-XR-based atrophic gastritis was diagnosed based on the irregular shape of areae gastricae and its expansion in the stomach.METHODSWe evaluated 6,901 healthy adults in Japan. UGI-XR-based atrophic gastritis was diagnosed based on the irregular shape of areae gastricae and its expansion in the stomach.Of the 6,433 subjects with no history of HP eradication and free from gastric acid suppressants, 1,936 were diagnosed as UGI-XR-based atrophic gastritis (mild: 234, moderate: 822, severe: 880). These were univariately associated with serum HP IgG and serum pepsinogen I/II ratio with statistical significance. The multiple logistic analysis calculating standardized coefficients (β) and odds ratio (OR) demonstrated that serum HP IgG (β = 1.499, OR = 4.48), current smoking (β = 0.526, OR = 1.69), age (β = 0.401, OR = 1.49), low serum pepsinogen I/II ratio (β = 0.339, OR = 1.40), and male gender (β = 0.306, OR = 1.36) showed significant positive association with UGI-XR-based atrophic gastritis whereas drinking and body mass index did not. Among the age/sex/smoking/drinking-matched 227 pairs derived from chronically HP-infected and successfully HP-eradicated subjects, UGI-XR-based atrophic gastritis was detected in 99.1% of the former but in only 59.5% of the latter subjects (p<0.0001). Contrastively, UGI-XR-based atrophic gastritis was detected in 13 of 14 HP-positive proton pump inhibitor users (92.9%) and 33 of 34 HP-positive histamine H2-receptor antagonist users (97.1%), which are not significantly different from gastric acid suppressant-free subjects.RESULTSOf the 6,433 subjects with no history of HP eradication and free from gastric acid suppressants, 1,936 were diagnosed as UGI-XR-based atrophic gastritis (mild: 234, moderate: 822, severe: 880). These were univariately associated with serum HP IgG and serum pepsinogen I/II ratio with statistical significance. The multiple logistic analysis calculating standardized coefficients (β) and odds ratio (OR) demonstrated that serum HP IgG (β = 1.499, OR = 4.48), current smoking (β = 0.526, OR = 1.69), age (β = 0.401, OR = 1.49), low serum pepsinogen I/II ratio (β = 0.339, OR = 1.40), and male gender (β = 0.306, OR = 1.36) showed significant positive association with UGI-XR-based atrophic gastritis whereas drinking and body mass index did not. Among the age/sex/smoking/drinking-matched 227 pairs derived from chronically HP-infected and successfully HP-eradicated subjects, UGI-XR-based atrophic gastritis was detected in 99.1% of the former but in only 59.5% of the latter subjects (p<0.0001). Contrastively, UGI-XR-based atrophic gastritis was detected in 13 of 14 HP-positive proton pump inhibitor users (92.9%) and 33 of 34 HP-positive histamine H2-receptor antagonist users (97.1%), which are not significantly different from gastric acid suppressant-free subjects.The presence of UGI-XR-based atrophic gastritis is positively associated with Helicobacter pylori infection, current smoking, age, decreased serum pepsinogen I/II ratio, and male gender. Eradication of Helicobacter pylori seems to superficially improve UGI-XR-based atrophic gastritis whereas intake of gastric acid suppressants does not.CONCLUSIONSThe presence of UGI-XR-based atrophic gastritis is positively associated with Helicobacter pylori infection, current smoking, age, decreased serum pepsinogen I/II ratio, and male gender. Eradication of Helicobacter pylori seems to superficially improve UGI-XR-based atrophic gastritis whereas intake of gastric acid suppressants does not. Background Double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It has been executed to find gastric cancer, but has not been usually executed to detect premalignant atrophic mucosa of stomach. To understand the meaning of UGI-XR-based atrophic gastritis, we analyzed its association with several causative factors including Helicobacter pylori (HP) infection. Methods We evaluated 6,901 healthy adults in Japan. UGI-XR-based atrophic gastritis was diagnosed based on the irregular shape of areae gastricae and its expansion in the stomach. Results Of the 6,433 subjects with no history of HP eradication and free from gastric acid suppressants, 1,936 were diagnosed as UGI-XR-based atrophic gastritis (mild: 234, moderate: 822, severe: 880). These were univariately associated with serum HP IgG and serum pepsinogen I/II ratio with statistical significance. The multiple logistic analysis calculating standardized coefficients (β) and odds ratio (OR) demonstrated that serum HP IgG (β = 1.499, OR = 4.48), current smoking (β = 0.526, OR = 1.69), age (β = 0.401, OR = 1.49), low serum pepsinogen I/II ratio (β = 0.339, OR = 1.40), and male gender (β = 0.306, OR = 1.36) showed significant positive association with UGI-XR-based atrophic gastritis whereas drinking and body mass index did not. Among the age/sex/smoking/drinking-matched 227 pairs derived from chronically HP-infected and successfully HP-eradicated subjects, UGI-XR-based atrophic gastritis was detected in 99.1% of the former but in only 59.5% of the latter subjects (p<0.0001). Contrastively, UGI-XR-based atrophic gastritis was detected in 13 of 14 HP-positive proton pump inhibitor users (92.9%) and 33 of 34 HP-positive histamine H2-receptor antagonist users (97.1%), which are not significantly different from gastric acid suppressant-free subjects. Conclusions The presence of UGI-XR-based atrophic gastritis is positively associated with Helicobacter pylori infection, current smoking, age, decreased serum pepsinogen I/II ratio, and male gender. Eradication of Helicobacter pylori seems to superficially improve UGI-XR-based atrophic gastritis whereas intake of gastric acid suppressants does not. Background Double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It has been executed to find gastric cancer, but has not been usually executed to detect premalignant atrophic mucosa of stomach. To understand the meaning of UGI-XR-based atrophic gastritis, we analyzed its association with several causative factors including Helicobacter pylori (HP) infection. Methods We evaluated 6,901 healthy adults in Japan. UGI-XR-based atrophic gastritis was diagnosed based on the irregular shape of areae gastricae and its expansion in the stomach. Results Of the 6,433 subjects with no history of HP eradication and free from gastric acid suppressants, 1,936 were diagnosed as UGI-XR-based atrophic gastritis (mild: 234, moderate: 822, severe: 880). These were univariately associated with serum HP IgG and serum pepsinogen I/II ratio with statistical significance. The multiple logistic analysis calculating standardized coefficients ([beta]) and odds ratio (OR) demonstrated that serum HP IgG ([beta] = 1.499, OR = 4.48), current smoking ([beta] = 0.526, OR = 1.69), age ([beta] = 0.401, OR = 1.49), low serum pepsinogen I/II ratio ([beta] = 0.339, OR = 1.40), and male gender ([beta] = 0.306, OR = 1.36) showed significant positive association with UGI-XR-based atrophic gastritis whereas drinking and body mass index did not. Among the age/sex/smoking/drinking-matched 227 pairs derived from chronically HP-infected and successfully HP-eradicated subjects, UGI-XR-based atrophic gastritis was detected in 99.1% of the former but in only 59.5% of the latter subjects (p<0.0001). Contrastively, UGI-XR-based atrophic gastritis was detected in 13 of 14 HP-positive proton pump inhibitor users (92.9%) and 33 of 34 HP-positive histamine H.sub.2 -receptor antagonist users (97.1%), which are not significantly different from gastric acid suppressant-free subjects. Conclusions The presence of UGI-XR-based atrophic gastritis is positively associated with Helicobacter pylori infection, current smoking, age, decreased serum pepsinogen I/II ratio, and male gender. Eradication of Helicobacter pylori seems to superficially improve UGI-XR-based atrophic gastritis whereas intake of gastric acid suppressants does not. Double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It has been executed to find gastric cancer, but has not been usually executed to detect premalignant atrophic mucosa of stomach. To understand the meaning of UGI-XR-based atrophic gastritis, we analyzed its association with several causative factors including Helicobacter pylori (HP) infection. We evaluated 6,901 healthy adults in Japan. UGI-XR-based atrophic gastritis was diagnosed based on the irregular shape of areae gastricae and its expansion in the stomach. Of the 6,433 subjects with no history of HP eradication and free from gastric acid suppressants, 1,936 were diagnosed as UGI-XR-based atrophic gastritis (mild: 234, moderate: 822, severe: 880). These were univariately associated with serum HP IgG and serum pepsinogen I/II ratio with statistical significance. The multiple logistic analysis calculating standardized coefficients (β) and odds ratio (OR) demonstrated that serum HP IgG (β = 1.499, OR = 4.48), current smoking (β = 0.526, OR = 1.69), age (β = 0.401, OR = 1.49), low serum pepsinogen I/II ratio (β = 0.339, OR = 1.40), and male gender (β = 0.306, OR = 1.36) showed significant positive association with UGI-XR-based atrophic gastritis whereas drinking and body mass index did not. Among the age/sex/smoking/drinking-matched 227 pairs derived from chronically HP-infected and successfully HP-eradicated subjects, UGI-XR-based atrophic gastritis was detected in 99.1% of the former but in only 59.5% of the latter subjects (p<0.0001). Contrastively, UGI-XR-based atrophic gastritis was detected in 13 of 14 HP-positive proton pump inhibitor users (92.9%) and 33 of 34 HP-positive histamine H2-receptor antagonist users (97.1%), which are not significantly different from gastric acid suppressant-free subjects. The presence of UGI-XR-based atrophic gastritis is positively associated with Helicobacter pylori infection, current smoking, age, decreased serum pepsinogen I/II ratio, and male gender. Eradication of Helicobacter pylori seems to superficially improve UGI-XR-based atrophic gastritis whereas intake of gastric acid suppressants does not. Background Double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It has been executed to find gastric cancer, but has not been usually executed to detect premalignant atrophic mucosa of stomach. To understand the meaning of UGI-XR-based atrophic gastritis, we analyzed its association with several causative factors including Helicobacter pylori (HP) infection. Methods We evaluated 6,901 healthy adults in Japan. UGI-XR-based atrophic gastritis was diagnosed based on the irregular shape of areae gastricae and its expansion in the stomach. Results Of the 6,433 subjects with no history of HP eradication and free from gastric acid suppressants, 1,936 were diagnosed as UGI-XR-based atrophic gastritis (mild: 234, moderate: 822, severe: 880). These were univariately associated with serum HP IgG and serum pepsinogen I/II ratio with statistical significance. The multiple logistic analysis calculating standardized coefficients (β) and odds ratio (OR) demonstrated that serum HP IgG (β = 1.499, OR = 4.48), current smoking (β = 0.526, OR = 1.69), age (β = 0.401, OR = 1.49), low serum pepsinogen I/II ratio (β = 0.339, OR = 1.40), and male gender (β = 0.306, OR = 1.36) showed significant positive association with UGI-XR-based atrophic gastritis whereas drinking and body mass index did not. Among the age/sex/smoking/drinking-matched 227 pairs derived from chronically HP-infected and successfully HP-eradicated subjects, UGI-XR-based atrophic gastritis was detected in 99.1% of the former but in only 59.5% of the latter subjects ( p <0.0001). Contrastively, UGI-XR-based atrophic gastritis was detected in 13 of 14 HP-positive proton pump inhibitor users (92.9%) and 33 of 34 HP-positive histamine H 2 -receptor antagonist users (97.1%), which are not significantly different from gastric acid suppressant-free subjects. Conclusions The presence of UGI-XR-based atrophic gastritis is positively associated with Helicobacter pylori infection, current smoking, age, decreased serum pepsinogen I/II ratio, and male gender. Eradication of Helicobacter pylori seems to superficially improve UGI-XR-based atrophic gastritis whereas intake of gastric acid suppressants does not. Double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It has been executed to find gastric cancer, but has not been usually executed to detect premalignant atrophic mucosa of stomach. To understand the meaning of UGI-XR-based atrophic gastritis, we analyzed its association with several causative factors including Helicobacter pylori (HP) infection.We evaluated 6,901 healthy adults in Japan. UGI-XR-based atrophic gastritis was diagnosed based on the irregular shape of areae gastricae and its expansion in the stomach.Of the 6,433 subjects with no history of HP eradication and free from gastric acid suppressants, 1,936 were diagnosed as UGI-XR-based atrophic gastritis (mild: 234, moderate: 822, severe: 880). These were univariately associated with serum HP IgG and serum pepsinogen I/II ratio with statistical significance. The multiple logistic analysis calculating standardized coefficients (β) and odds ratio (OR) demonstrated that serum HP IgG (β = 1.499, OR = 4.48), current smoking (β = 0.526, OR = 1.69), age (β = 0.401, OR = 1.49), low serum pepsinogen I/II ratio (β = 0.339, OR = 1.40), and male gender (β = 0.306, OR = 1.36) showed significant positive association with UGI-XR-based atrophic gastritis whereas drinking and body mass index did not. Among the age/sex/smoking/drinking-matched 227 pairs derived from chronically HP-infected and successfully HP-eradicated subjects, UGI-XR-based atrophic gastritis was detected in 99.1% of the former but in only 59.5% of the latter subjects (p<0.0001). Contrastively, UGI-XR-based atrophic gastritis was detected in 13 of 14 HP-positive proton pump inhibitor users (92.9%) and 33 of 34 HP-positive histamine H2-receptor antagonist users (97.1%), which are not significantly different from gastric acid suppressant-free subjects.The presence of UGI-XR-based atrophic gastritis is positively associated with Helicobacter pylori infection, current smoking, age, decreased serum pepsinogen I/II ratio, and male gender. Eradication of Helicobacter pylori seems to superficially improve UGI-XR-based atrophic gastritis whereas intake of gastric acid suppressants does not. |
| Audience | Academic |
| Author | Asada-Hirayama, Itsuko Tsuji, Yosuke Kato, Jun Yakabi, Seiichi Konno-Shimizu, Maki Mitsushima, Toru Hirano, Chigaya Nakayama, Chiemi Matsuda, Rie Kodashima, Shinya Takahashi, Yu Fujishiro, Mitsuhiro Mochizuki, Satoshi Minatsuki, Chihiro Koike, Kazuhiko Sakaguchi, Yoshiki Takeuchi, Chihiro Wada, Ryoichi Yamamichi, Nobutake Shimamoto, Takeshi Niimi, Keiko Ichinose, Masao Kakimoto, Hikaru Ono, Satoshi |
| AuthorAffiliation | Okayama University, Japan 2 Department of Gastroenterology, Kameda Medical Center Makuhari, Chiba, Japan 1 Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan 3 Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan |
| AuthorAffiliation_xml | – name: 1 Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan – name: 2 Department of Gastroenterology, Kameda Medical Center Makuhari, Chiba, Japan – name: Okayama University, Japan – name: 3 Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan |
| Author_xml | – sequence: 1 givenname: Nobutake surname: Yamamichi fullname: Yamamichi, Nobutake – sequence: 2 givenname: Chigaya surname: Hirano fullname: Hirano, Chigaya – sequence: 3 givenname: Takeshi surname: Shimamoto fullname: Shimamoto, Takeshi – sequence: 4 givenname: Chihiro surname: Minatsuki fullname: Minatsuki, Chihiro – sequence: 5 givenname: Yu surname: Takahashi fullname: Takahashi, Yu – sequence: 6 givenname: Chiemi surname: Nakayama fullname: Nakayama, Chiemi – sequence: 7 givenname: Rie surname: Matsuda fullname: Matsuda, Rie – sequence: 8 givenname: Mitsuhiro surname: Fujishiro fullname: Fujishiro, Mitsuhiro – sequence: 9 givenname: Maki surname: Konno-Shimizu fullname: Konno-Shimizu, Maki – sequence: 10 givenname: Jun surname: Kato fullname: Kato, Jun – sequence: 11 givenname: Shinya surname: Kodashima fullname: Kodashima, Shinya – sequence: 12 givenname: Satoshi surname: Ono fullname: Ono, Satoshi – sequence: 13 givenname: Keiko surname: Niimi fullname: Niimi, Keiko – sequence: 14 givenname: Satoshi surname: Mochizuki fullname: Mochizuki, Satoshi – sequence: 15 givenname: Yosuke surname: Tsuji fullname: Tsuji, Yosuke – sequence: 16 givenname: Yoshiki surname: Sakaguchi fullname: Sakaguchi, Yoshiki – sequence: 17 givenname: Itsuko surname: Asada-Hirayama fullname: Asada-Hirayama, Itsuko – sequence: 18 givenname: Chihiro surname: Takeuchi fullname: Takeuchi, Chihiro – sequence: 19 givenname: Seiichi surname: Yakabi fullname: Yakabi, Seiichi – sequence: 20 givenname: Hikaru surname: Kakimoto fullname: Kakimoto, Hikaru – sequence: 21 givenname: Ryoichi surname: Wada fullname: Wada, Ryoichi – sequence: 22 givenname: Toru surname: Mitsushima fullname: Mitsushima, Toru – sequence: 23 givenname: Masao surname: Ichinose fullname: Ichinose, Masao – sequence: 24 givenname: Kazuhiko surname: Koike fullname: Koike, Kazuhiko |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25343257$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk12L1DAUhousuB_6D0QDgijYMWnSpt0LYZx1P2RhYccV70KaJp0MnaYmqVh_mT_PdGZWdpZFJBcNJ895k_P2nMNorzWtjKLnCE4Qpuj90vS25c2kC-EJRAjhtHgUHaACJ3GWQLx3Z78fHTq3hDDFeZY9ifaTFBOcpPQg-j11zgjNvazAKRfeWAeMAlNvTbfQApxx56322oETzevWuMCVAzgxfdnIeGZabwMBbrpO2g1sdOul8zq8DXzkVvcr8C2-5gO45pU2teXdYjgGUzCzxrl4LoXXZmTnvq8GMA3b4Zdua5C9KyAC55I3fjGAeV8uA-qAbsFn3vH2afRY8cbJZ9vvUXRz-unL7Dy-vDq7mE0vY5HluY-roqIUJgkkFRUUlZSgEsuEEy55IUuBBc2VKrAgOVUKYUKLIpMqrTIlcCEwPopebnS7xji2Nd0xlIVFE0xhIC42RGX4knVWr7gdmOGarQPG1oxbr0UjmZQKlURwiLOMVGWVK6JwIlKMc4hLRYLWh-1tfbmSlZCjv82O6O5JqxesNj8YSWCeYxoE3mwFrPneh__AVtoJ2TS8laZfvztHKSnSEX11D324ui1V81CAbpUJ94pRlE0JojnBRZYEavIAFVYlV1qEDlU6xHcS3u4kBMbLn77mvXPsYn79_-zV11329R12se4eZ5p-bDK3C7646_Rfi29HIwDHG0CMjWqlYkJ7PuqE0nTDEGTjHN6axsY5ZNs5DMnkXvKt_j_T_gBz3zkI |
| CitedBy_id | crossref_primary_10_1007_s10120_016_0607_3 crossref_primary_10_3892_ol_2023_13764 crossref_primary_10_1007_s11604_018_0782_8 crossref_primary_10_1186_s12876_015_0247_9 crossref_primary_10_1007_s12328_021_01445_z crossref_primary_10_3892_mco_2019_1804 crossref_primary_10_1007_s10120_015_0515_y crossref_primary_10_1002_jhbp_1018 crossref_primary_10_1371_journal_pone_0123688 crossref_primary_10_1093_jjco_hyac097 crossref_primary_10_1016_j_talanta_2024_126860 crossref_primary_10_4251_wjgo_v10_i2_62 crossref_primary_10_1177_1756284819858511 crossref_primary_10_1007_s10120_015_0558_0 crossref_primary_10_1371_journal_pone_0170416 crossref_primary_10_1007_s11604_015_0469_3 |
| Cites_doi | 10.1371/journal.pone.0065996 10.1136/gut.49.3.335 10.1055/s-0028-1098086 10.1371/journal.pone.0069891 10.1002/ijc.11680 10.1046/j.1365-2036.2002.01311.x 10.1111/j.1572-0241.2003.07410.x 10.1093/oxfordjournals.epirev.a018040 10.1136/gut.2004.055400 10.1053/gast.2000.8550 10.1259/bjr.75.898.750805 10.7326/0003-4819-151-2-200907210-00009 10.1053/j.gastro.2007.06.026 10.3748/wjg.v18.i32.4412 10.1093/jjco/hyn017 10.1093/aje/kwj088 10.1056/NEJMoa001999 10.7326/0003-4819-134-5-200103060-00010 10.1158/0008-5472.CAN-07-2601 10.1136/gut.2003.034629 10.1007/PL00011692 10.1002/ijc.11183 10.1080/00365520802085395 10.1186/1471-230X-11-140 10.1007/s10120-006-0397-0 10.3748/wjg.v12.i3.354 10.1007/s00535-013-0832-z 10.1002/ijc.2910380608 10.1111/j.1443-1661.2012.01385.x 10.1038/nrc2857 10.1111/j.1523-5378.2009.00681.x 10.1002/ijc.21664 10.1016/S0016-5085(19)33241-X 10.1586/egh.10.7 10.1016/S1470-2045(08)70072-X 10.1148/radiol.2461061245 10.1093/jnci/92.23.1881 10.1111/j.1440-1746.2009.06214.x 10.1001/jama.291.2.187 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2014 Public Library of Science 2014 Yamamichi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2014 Yamamichi et al 2014 Yamamichi et al |
| Copyright_xml | – notice: COPYRIGHT 2014 Public Library of Science – notice: 2014 Yamamichi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2014 Yamamichi et al 2014 Yamamichi et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0111359 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts ProQuest Nursing & Allied Health Database (NC LIVE) Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest Public Health Database (NC LIVE) Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection (ProQuest) Natural Science Collection (ProQuest) Environmental Sciences and Pollution Management ProQuest One ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Materials Science Database (NC LIVE) Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Agricultural Science Database MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Open Access Full Text url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Medicine |
| DocumentTitleAlternate | Associated Factors of Barium X-Ray-Based Atrophic Gastritis |
| EISSN | 1932-6203 |
| ExternalDocumentID | 1616172370 oai_doaj_org_article_eef1b4ca03664dbd8f4f32c533803bf4 PMC4208837 3470808411 A417843962 25343257 10_1371_journal_pone_0111359 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Japan |
| GeographicLocations_xml | – name: Japan |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PYCSY RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM CGR CUY CVF ECM EIF IPNFZ NPM PJZUB PPXIY PQGLB PV9 RIG RZL BBORY PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 5PM PUEGO - 02 AAPBV ABPTK ADACO BBAFP KM |
| ID | FETCH-LOGICAL-c688t-d9d7702204d7c71b741b3e2a4aea9ebc3c78ff93c487ff1347996ef5d6fc39c33 |
| IEDL.DBID | M48 |
| ISSN | 1932-6203 |
| IngestDate | Fri Nov 26 17:14:07 EST 2021 Wed Aug 27 01:30:45 EDT 2025 Thu Aug 21 13:57:51 EDT 2025 Mon Jul 21 11:15:15 EDT 2025 Fri Jul 25 10:09:09 EDT 2025 Tue Jun 17 21:25:48 EDT 2025 Tue Jun 10 20:24:50 EDT 2025 Fri Jun 27 04:41:40 EDT 2025 Fri Jun 27 04:18:48 EDT 2025 Thu May 22 21:22:30 EDT 2025 Mon Jul 21 06:07:21 EDT 2025 Thu Apr 24 22:49:09 EDT 2025 Tue Jul 01 03:26:58 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c688t-d9d7702204d7c71b741b3e2a4aea9ebc3c78ff93c487ff1347996ef5d6fc39c33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors have declared that no competing interests exist. Conceived and designed the experiments: NY CH TS TM MI. Performed the experiments: NY CH CM Y. Takahashi CN RM MKS. Analyzed the data: NY TS SK SO KN SM Y. Tsuji YS IAH CT SY HK RW. Contributed reagents/materials/analysis tools: NY CH TM. Contributed to the writing of the manuscript: NY CH TS MF JK MI KK. |
| OpenAccessLink | https://www.proquest.com/docview/1616172370?pq-origsite=%requestingapplication% |
| PMID | 25343257 |
| PQID | 1616172370 |
| PQPubID | 1436336 |
| ParticipantIDs | plos_journals_1616172370 doaj_primary_oai_doaj_org_article_eef1b4ca03664dbd8f4f32c533803bf4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4208837 proquest_miscellaneous_1618154957 proquest_journals_1616172370 gale_infotracmisc_A417843962 gale_infotracacademiconefile_A417843962 gale_incontextgauss_ISR_A417843962 gale_incontextgauss_IOV_A417843962 gale_healthsolutions_A417843962 pubmed_primary_25343257 crossref_citationtrail_10_1371_journal_pone_0111359 crossref_primary_10_1371_journal_pone_0111359 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2014-10-24 |
| PublicationDateYYYYMMDD | 2014-10-24 |
| PublicationDate_xml | – month: 10 year: 2014 text: 2014-10-24 day: 24 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2014 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | DB Polk (ref18) 2010; 10 WK Leung (ref3) 2008; 9 S Dheer (ref21) 2002; 75 KD Crew (ref1) 2006; 12 JJ Sung (ref36) 2000; 119 C Hamashima (ref9) 2008; 38 S Hisamichi (ref7) 1984; 14 K Miki (ref11) 2003; 98 Y Yamaji (ref34) 2001; 49 K Kimura (ref25) 1969; 3 K Miki (ref35) 2006; 9 BC Wong (ref41) 2004; 291 LM Brown (ref14) 2000; 22 T Shimamoto (ref28) 2013; 8 M Kato (ref38) 2013; 25 T Mizoue (ref8) 2003; 106 M Tatemichi (ref29) 2009; 14 H Ohata (ref30) 2004; 109 S Shiota (ref33) 2010; 4 ref26 P Correa (ref39) 2000; 92 Y Tsubono (ref5) 2000; 3 O Hosokawa (ref10) 2008; 43 H Watabe (ref32) 2005; 54 N Yamamichi (ref23) 2011; 11 P Correa (ref43) 2007; 133 J Bures (ref15) 2012; 18 SE Rubesin (ref22) 2008; 246 K Kimura (ref24) 1972; 63 L Fuccio (ref40) 2009; 151 N Yamamichi (ref2) 2007; 67 KJ Lee (ref4) 2006; 118 MF Dixon (ref16) 1996; 20 N Uemura (ref17) 2001; 345 A Oshima (ref6) 1986; 38 K Satoh (ref19) 1996; 91 M Ito (ref37) 2002; 16 WK Leung (ref42) 2004; 53 T Ohkusa (ref20) 2001; 134 C Minatsuki (ref27) 2013; 8 SY Lee (ref13) 2007; 54 S Nakajima (ref12) 2010; 25 Y Oishi (ref31) 2006; 163 14735480 - Int J Cancer. 2004 Mar10;109(1):138-43 20495574 - Nat Rev Cancer. 2010 Jun;10(6):403-14 16489633 - World J Gastroenterol. 2006 Jan 21;12(3):354-62 22969207 - World J Gastroenterol. 2012 Aug 28;18(32):4412-8 23369104 - Dig Endosc. 2013 May;25(3):264-73 22189089 - BMC Gastroenterol. 2011;11:140 11242498 - Ann Intern Med. 2001 Mar 6;134(5):380-6 20586876 - J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S99-S110 8827022 - Am J Surg Pathol. 1996 Oct;20(10):1161-81 17681184 - Gastroenterology. 2007 Aug;133(2):659-72 11984703 - Gastric Cancer. 2000 Aug 4;3(1):9-18 23922844 - PLoS One. 2013;8(7):e69891 19620164 - Ann Intern Med. 2009 Jul 21;151(2):121-8 17523338 - Hepatogastroenterology. 2007 Mar;54(74):630-3 11556297 - N Engl J Med. 2001 Sep 13;345(11):784-9 11106679 - J Natl Cancer Inst. 2000 Dec 6;92(23):1881-8 11511553 - Gut. 2001 Sep;49(3):335-40 16443800 - Am J Epidemiol. 2006 Apr 1;163(7):629-37 12381689 - Br J Radiol. 2002 Oct;75(898):805-11 18308253 - Lancet Oncol. 2008 Mar;9(3):279-87 5077145 - Gastroenterology. 1972 Oct;63(4):584-92 17235625 - Gastric Cancer. 2006;9(4):245-53 12738449 - Am J Gastroenterol. 2003 Apr;98(4):735-9 20350262 - Expert Rev Gastroenterol Hepatol. 2010 Apr;4(2):149-56 18006815 - Cancer Res. 2007 Nov 15;67(22):10727-35 14722144 - JAMA. 2004 Jan 14;291(2):187-94 12182744 - Aliment Pharmacol Ther. 2002 Aug;16(8):1449-56 6737710 - Jpn J Clin Oncol. 1984 Jun;14(2):211-23 11218379 - Epidemiol Rev. 2000;22(2):283-97 15306578 - Gut. 2004 Sep;53(9):1244-9 16331632 - Int J Cancer. 2006 May 1;118(9):2315-21 18096527 - Radiology. 2008 Jan;246(1):33-48 18344316 - Jpn J Clin Oncol. 2008 Apr;38(4):259-67 19702853 - Helicobacter. 2009 Jun;14(3):231-6 23776588 - PLoS One. 2013;8(6):e65996 18609154 - Scand J Gastroenterol. 2008;43(9):1112-5 23736795 - J Gastroenterol. 2014 May;49(5):882-9 15888780 - Gut. 2005 Jun;54(6):764-8 10889149 - Gastroenterology. 2000 Jul;119(1):7-14 8633589 - Am J Gastroenterol. 1996 May;91(5):963-9 12794764 - Int J Cancer. 2003 Aug 10;106(1):103-7 3793262 - Int J Cancer. 1986 Dec 15;38(6):829-33 |
| References_xml | – volume: 8 start-page: e65996 year: 2013 ident: ref28 article-title: No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a cross-sectional study of 8,013 healthy subjects in Japan publication-title: PLoS One doi: 10.1371/journal.pone.0065996 – volume: 49 start-page: 335 year: 2001 ident: ref34 article-title: Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects publication-title: Gut doi: 10.1136/gut.49.3.335 – volume: 20 start-page: 1161 year: 1996 ident: ref16 article-title: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994 publication-title: Am J Surg Pathol – volume: 3 start-page: 87 year: 1969 ident: ref25 article-title: An Endoscopic Recognition of the Atrophic Border and its Significance in Chronic Gastritis publication-title: Endoscopy doi: 10.1055/s-0028-1098086 – volume: 8 start-page: e69891 year: 2013 ident: ref27 article-title: Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan publication-title: PLoS One doi: 10.1371/journal.pone.0069891 – volume: 109 start-page: 138 year: 2004 ident: ref30 article-title: Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer publication-title: Int J Cancer doi: 10.1002/ijc.11680 – volume: 16 start-page: 1449 year: 2002 ident: ref37 article-title: Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis publication-title: Aliment Pharmacol Ther doi: 10.1046/j.1365-2036.2002.01311.x – volume: 98 start-page: 735 year: 2003 ident: ref11 article-title: Usefulness of gastric cancer screening using the serum pepsinogen test method publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2003.07410.x – volume: 22 start-page: 283 year: 2000 ident: ref14 article-title: Helicobacter pylori: epidemiology and routes of transmission publication-title: Epidemiol Rev doi: 10.1093/oxfordjournals.epirev.a018040 – volume: 54 start-page: 764 year: 2005 ident: ref32 article-title: Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study publication-title: Gut doi: 10.1136/gut.2004.055400 – volume: 119 start-page: 7 year: 2000 ident: ref36 article-title: Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study publication-title: Gastroenterology doi: 10.1053/gast.2000.8550 – volume: 75 start-page: 805 year: 2002 ident: ref21 article-title: Radiographically diagnosed antral gastritis: findings in patients with and without Helicobacter pylori infection publication-title: Br J Radiol doi: 10.1259/bjr.75.898.750805 – volume: 151 start-page: 121 year: 2009 ident: ref40 article-title: Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? publication-title: Ann Intern Med doi: 10.7326/0003-4819-151-2-200907210-00009 – volume: 133 start-page: 659 year: 2007 ident: ref43 article-title: Carcinogenesis of Helicobacter pylori publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.06.026 – volume: 14 start-page: 211 year: 1984 ident: ref7 article-title: Mass screening for gastric cancer by X-ray examination publication-title: Jpn J Clin Oncol – volume: 18 start-page: 4412 year: 2012 ident: ref15 article-title: Significant decrease in prevalence of Helicobacter pylori in the Czech Republic publication-title: World J Gastroenterol doi: 10.3748/wjg.v18.i32.4412 – volume: 38 start-page: 259 year: 2008 ident: ref9 article-title: The Japanese guidelines for gastric cancer screening publication-title: Jpn J Clin Oncol doi: 10.1093/jjco/hyn017 – volume: 163 start-page: 629 year: 2006 ident: ref31 article-title: The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study publication-title: Am J Epidemiol doi: 10.1093/aje/kwj088 – volume: 345 start-page: 784 year: 2001 ident: ref17 article-title: Helicobacter pylori infection and the development of gastric cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa001999 – volume: 134 start-page: 380 year: 2001 ident: ref20 article-title: Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated publication-title: Ann Intern Med doi: 10.7326/0003-4819-134-5-200103060-00010 – volume: 67 start-page: 10727 year: 2007 ident: ref2 article-title: Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-2601 – volume: 53 start-page: 1244 year: 2004 ident: ref42 article-title: Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication publication-title: Gut doi: 10.1136/gut.2003.034629 – volume: 3 start-page: 9 year: 2000 ident: ref5 article-title: Screening for gastric cancer in Japan publication-title: Gastric Cancer doi: 10.1007/PL00011692 – volume: 106 start-page: 103 year: 2003 ident: ref8 article-title: Prospective study of screening for stomach cancer in Japan publication-title: Int J Cancer doi: 10.1002/ijc.11183 – volume: 43 start-page: 1112 year: 2008 ident: ref10 article-title: Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry publication-title: Scand J Gastroenterol doi: 10.1080/00365520802085395 – volume: 11 start-page: 140 year: 2011 ident: ref23 article-title: Postprandial fullness correlates with rapid inflow of gastric content into duodenum but not with chronic gastritis publication-title: BMC Gastroenterol doi: 10.1186/1471-230X-11-140 – volume: 9 start-page: 245 year: 2006 ident: ref35 article-title: Gastric cancer screening using the serum pepsinogen test method publication-title: Gastric Cancer doi: 10.1007/s10120-006-0397-0 – volume: 12 start-page: 354 year: 2006 ident: ref1 article-title: Epidemiology of gastric cancer publication-title: World J Gastroenterol doi: 10.3748/wjg.v12.i3.354 – ident: ref26 doi: 10.1007/s00535-013-0832-z – volume: 38 start-page: 829 year: 1986 ident: ref6 article-title: Evaluation of a mass screening program for stomach cancer with a case-control study design publication-title: Int J Cancer doi: 10.1002/ijc.2910380608 – volume: 25 start-page: 264 year: 2013 ident: ref38 article-title: Changes in endoscopic findings of gastritis after cure of H. pylori infection: multicenter prospective trial publication-title: Dig Endosc doi: 10.1111/j.1443-1661.2012.01385.x – volume: 10 start-page: 403 year: 2010 ident: ref18 article-title: Helicobacter pylori: gastric cancer and beyond publication-title: Nat Rev Cancer doi: 10.1038/nrc2857 – volume: 91 start-page: 963 year: 1996 ident: ref19 article-title: Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis publication-title: Am J Gastroenterol – volume: 14 start-page: 231 year: 2009 ident: ref29 article-title: Clinical significance of IgG antibody titer against Helicobacter pylori publication-title: Helicobacter doi: 10.1111/j.1523-5378.2009.00681.x – volume: 54 start-page: 630 year: 2007 ident: ref13 article-title: Decreasing prevalence of Helicobacter pylori infection: a 9-year observational study publication-title: Hepatogastroenterology – volume: 118 start-page: 2315 year: 2006 ident: ref4 article-title: Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan publication-title: Int J Cancer doi: 10.1002/ijc.21664 – volume: 63 start-page: 584 year: 1972 ident: ref24 article-title: Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach publication-title: Gastroenterology doi: 10.1016/S0016-5085(19)33241-X – volume: 4 start-page: 149 year: 2010 ident: ref33 article-title: Population-based strategies for Helicobacter pylori-associated disease management: a Japanese perspective publication-title: Expert Rev Gastroenterol Hepatol doi: 10.1586/egh.10.7 – volume: 9 start-page: 279 year: 2008 ident: ref3 article-title: Screening for gastric cancer in Asia: current evidence and practice publication-title: Lancet Oncol doi: 10.1016/S1470-2045(08)70072-X – volume: 246 start-page: 33 year: 2008 ident: ref22 article-title: Double-contrast upper gastrointestinal radiography: a pattern approach for diseases of the stomach publication-title: Radiology doi: 10.1148/radiol.2461061245 – volume: 92 start-page: 1881 year: 2000 ident: ref39 article-title: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy publication-title: J Natl Cancer Inst doi: 10.1093/jnci/92.23.1881 – volume: 25 start-page: S99 year: 2010 ident: ref12 article-title: Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2009.06214.x – volume: 291 start-page: 187 year: 2004 ident: ref41 article-title: Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial publication-title: JAMA doi: 10.1001/jama.291.2.187 – reference: 17681184 - Gastroenterology. 2007 Aug;133(2):659-72 – reference: 20586876 - J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S99-S110 – reference: 8827022 - Am J Surg Pathol. 1996 Oct;20(10):1161-81 – reference: 18006815 - Cancer Res. 2007 Nov 15;67(22):10727-35 – reference: 11106679 - J Natl Cancer Inst. 2000 Dec 6;92(23):1881-8 – reference: 18096527 - Radiology. 2008 Jan;246(1):33-48 – reference: 11511553 - Gut. 2001 Sep;49(3):335-40 – reference: 19702853 - Helicobacter. 2009 Jun;14(3):231-6 – reference: 23736795 - J Gastroenterol. 2014 May;49(5):882-9 – reference: 20495574 - Nat Rev Cancer. 2010 Jun;10(6):403-14 – reference: 17235625 - Gastric Cancer. 2006;9(4):245-53 – reference: 17523338 - Hepatogastroenterology. 2007 Mar;54(74):630-3 – reference: 12381689 - Br J Radiol. 2002 Oct;75(898):805-11 – reference: 15306578 - Gut. 2004 Sep;53(9):1244-9 – reference: 11218379 - Epidemiol Rev. 2000;22(2):283-97 – reference: 3793262 - Int J Cancer. 1986 Dec 15;38(6):829-33 – reference: 12794764 - Int J Cancer. 2003 Aug 10;106(1):103-7 – reference: 10889149 - Gastroenterology. 2000 Jul;119(1):7-14 – reference: 11556297 - N Engl J Med. 2001 Sep 13;345(11):784-9 – reference: 8633589 - Am J Gastroenterol. 1996 May;91(5):963-9 – reference: 23922844 - PLoS One. 2013;8(7):e69891 – reference: 23776588 - PLoS One. 2013;8(6):e65996 – reference: 16331632 - Int J Cancer. 2006 May 1;118(9):2315-21 – reference: 16489633 - World J Gastroenterol. 2006 Jan 21;12(3):354-62 – reference: 22969207 - World J Gastroenterol. 2012 Aug 28;18(32):4412-8 – reference: 6737710 - Jpn J Clin Oncol. 1984 Jun;14(2):211-23 – reference: 14735480 - Int J Cancer. 2004 Mar10;109(1):138-43 – reference: 5077145 - Gastroenterology. 1972 Oct;63(4):584-92 – reference: 12182744 - Aliment Pharmacol Ther. 2002 Aug;16(8):1449-56 – reference: 22189089 - BMC Gastroenterol. 2011;11:140 – reference: 14722144 - JAMA. 2004 Jan 14;291(2):187-94 – reference: 23369104 - Dig Endosc. 2013 May;25(3):264-73 – reference: 18308253 - Lancet Oncol. 2008 Mar;9(3):279-87 – reference: 18609154 - Scand J Gastroenterol. 2008;43(9):1112-5 – reference: 16443800 - Am J Epidemiol. 2006 Apr 1;163(7):629-37 – reference: 19620164 - Ann Intern Med. 2009 Jul 21;151(2):121-8 – reference: 12738449 - Am J Gastroenterol. 2003 Apr;98(4):735-9 – reference: 11984703 - Gastric Cancer. 2000 Aug 4;3(1):9-18 – reference: 15888780 - Gut. 2005 Jun;54(6):764-8 – reference: 11242498 - Ann Intern Med. 2001 Mar 6;134(5):380-6 – reference: 20350262 - Expert Rev Gastroenterol Hepatol. 2010 Apr;4(2):149-56 – reference: 18344316 - Jpn J Clin Oncol. 2008 Apr;38(4):259-67 |
| SSID | ssj0053866 |
| Score | 2.2252622 |
| Snippet | Double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It has been... Background Double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It... Background Double-contrast upper gastrointestinal barium X-ray radiography (UGI-XR) is one of the most widely conducted gastric cancer screening methods. It... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e111359 |
| SubjectTerms | Acids Adult Adults Age Aged Aged, 80 and over Analysis Background radiation Barium Biology and Life Sciences Body mass Body mass index Body size Cancer Cancer screening Chronic Disease Contrast Media Cross-Sectional Studies Diagnosis Diagnostic imaging Endoscopy Female Gastric cancer Gastric juice Gastritis Gastritis, Atrophic - complications Gastritis, Atrophic - diagnostic imaging Gastritis, Atrophic - microbiology Gastroenterology Gastrointestinal Tract - diagnostic imaging Gender Healthy Volunteers Helicobacter infections Helicobacter Infections - complications Helicobacter Infections - diagnostic imaging Helicobacter Infections - microbiology Helicobacter pylori Helicobacter pylori - physiology Histamine Histamine H2 Antagonists - therapeutic use Humans Immunoglobulin G Infections Internal medicine Japan Male Mathematical analysis Medical screening Medicine Medicine and Health Sciences Middle Aged Mortality Mucosa Multivariate Analysis Proton pump inhibitors Proton Pump Inhibitors - therapeutic use Radiography Smoking Statistical analysis Stomach Stomach cancer Ulcers X-ray radiography X-Rays Young Adult |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hnLggyquBAgtCAiTcOt7Nrs2tIKpSCZCAotysfbaRgh3F8SH8Mn4eM-uNFaNK5cA1-zmy57327DeEvBCp9lObu4RzWyTcaZXojItEamGkBBfUYfLcp8_i9JyfzaaznVFf2BPW0QN3gjtyzk80NwoireBW29xzzzIDVUqeMu0DEyjkvO1mqovB4MVCxINyTE6Ool4Ol3XlDsN0deQm3UlEga-_j8qj5aJurio5_-6c3ElFJ7fJrVhD0uPu3vfIDVfdIXvRSxv6KlJJv75Lfm-l7yyNk3Vo7Sm-_15ezg29UE0g42-o7VruAKc31NatXrgktLEDgrbLpVt14Br5JSAs4A1o2Ge3P-ksWakNXSk7j_TXb6mi4aGTJjR6ITbQ2FKFFCi_IFtS8QZKBNqdwtzQptX4Pqih84qeQfqu7pHzkw_f358mcVZDYkSerxNbWFBtlqXcSiMnGgoVzVymuHKqcNowI3PvC2Zgg-R9OL9aCAdmIrxhhWHsPhlVoJ19QrWBOkxP8Quk5JpjGNS4q7KpSC1k0zFhW8WVJhKZ4zyNRRm-zknY0HR6KFHdZVT3mCT9VcuOyOMa_Du0iR6LNNzhBzDOMhpneZ1xjslTtKiyk2YfTMpjPpE5lIIiG5PnAYFUHBX2-lyotmnKj19-_APo29cB6GUE-RrEYVQ8XwHPhBRfA-TBAAkBxQyW99H-t1JpStgUYJ3LZApXbn3i6uVn_TL-KfbvVa5uAyZHMsCpHJMHnQv1ks2meLgZV-TAuQaiH65U88vAhI69ITmTD_-Hrh6Rm1AMc6xLMn5ARutV6x5DwbnWT0Js-QOFKIOY priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELagSIgXxMaPFQYYhARIeEsT1055Qd2gjEkDqaNT36LYsbdKJQlN-1D-Mv487hw3LGgCXusvVeLznT_b5-8IeSECZftZbBjn2YBxo1KmQi6YVEJLCS6oXOW5k8_iaMKPp_2p33CrfFrlJia6QJ0VGvfI94GZ4GQbyeBd-Z1h1Sg8XfUlNK6TGyhdhildctosuMCXhfDX5SLZ2_fW2SuL3Oy5GuuoUHppOnKq_U1s7pTzorqKeP6ZP3lpQhrdIbc9k6TD2vRb5JrJt8nNE39Wvk22vNtW9JXXln59l_zcmMNkdFSX2qGFpcPloigvZpp-TCunzl_R93UOHuDUmgLNVnPDUMpqAQg6KUuzqMEFCk5AnMB3OYCF9-obnbJxuqbjNJt5Pey3dEgP8fvZqcv8QiwmMK6p00T5AdMnFW-AM9D6VtSaQjzDDaKKznJ6DPN5fo9MRh--Hh4xX7yBaRHHS5YNMrB1GAY8k1r2FDAXFZkw5alJB0bpSMvY2kGkYcVkrbvQOhAGxo2wOhroKLpPOjkYaodQpYGYqT4eSUquOMZFhcusLBBBBtNrl0QbGybaK5tjgY154o7rJKxwapMkaPnEW75LWPNUWSt7_AN_gMOjwaIut_uhWJwn3s0TY2xPcZ0CLxA8U1lsuY1CDZw6DiJl4VWf4uBK6kuuTXRJhrwnY-CGIuyS5w6B2hw5Jv-cp6uqSj59OfsP0Om4BXrpQbaA7tCpv3AB34SaXy3kbgsJEUa3mnfQFTa9UiW_fRGe3LjH1c3Pmmb8U0zoy02xcpgY1QH7skse1N7U9GzYx9vO2CJbftbq-nZLPrtw0uiYLBJH8uHfX-sRuQW8lyMFCfku6SwXK_MYuOVSPXEB5Bdt83s8 priority: 102 providerName: ProQuest |
| Title | Associated Factors of Atrophic Gastritis Diagnosed by Double-Contrast Upper Gastrointestinal Barium X-Ray Radiography: A Cross-Sectional Study Analyzing 6,901 Healthy Subjects in Japan |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/25343257 https://www.proquest.com/docview/1616172370 https://www.proquest.com/docview/1618154957 https://pubmed.ncbi.nlm.nih.gov/PMC4208837 https://doaj.org/article/eef1b4ca03664dbd8f4f32c533803bf4 http://dx.doi.org/10.1371/journal.pone.0111359 |
| Volume | 9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELe27oUXxPhaYRSDkACJVG3i2gkSQtu0MiZtoMFQ36L4I12lkpSmkSh_GX8ed44TLagTvOQh_jlKfD7fnXP-HSEv-ECmIx0ajzEdeczIxJM-456QXAkBKiht5bmzc35yyU4no8kWqWu2ugEsNoZ2WE_qcjnv__yxfg8K_85WbRDDulN_kWemb2unj6JtsgO2SaCqnrHmvwJoN-fuAN1NPZEeeITHLdFiXbNVltK_Wbg7i3lebPJK_06uvGatxnfIbedm0oNqXuySLZPdJbtOkQv6yrFNv75HftcCMpq64js0TylukS-uZopOk8Ly9RdUV1l5gJNrqvNSzo1nM90BQcvFwiwrcI4UFLBy4AtICMXL73TiLZM1XSZ65hiy39KE2o_2CpsLhljLdEsTZEn5BQaV8jfgRdDqoOaaFqXELaOCzjJ6ChY-u08ux8dfj048V87BUzwMV56ONEjf9wdMCyWGEnwZGRg_YYlJIiNVoESYplGgIIZKU3vENeIGZhJPVRCpIHhAOhkIao9QqcBVkyP8SSmYZLhSSgy89IAPNBjcLglqwcXKcZ1jyY15bH_gCYh5KjnEKPnYSb5LvKbXouL6-Af-EOdEg0WmbnsjX05jp_ixMelQMpWAp8CZljpMWRr4CrzscBDIFF71Kc6ouBrNZr2JD2D2huAtcr9LnlsEsnVkmA40TcqiiD9--vYfoC8XLdBLB0pzGA6VuCMY8E3IAtZC7reQsOaoVvMezv96VIoY4gZ0hQMxgJ61TmxuftY040MxxS8zeWkxIfIFjkSXPKxUqBnZWiG7RLSUqzX07ZZsdmXJ0jF9JAzEoxuf-ZjcAieYoT_is33SWS1L8wQczZXskW0xEXANj4Z4HX_okZ3D4_PPFz27ddOza8sfWrKFGA |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamIQEviI3LCoMZBAIksqWJa6dICHUbZd0NqdtQ30LsOFulkYSmFSo_imd-Huc4TljQBLzstT6pHB-f73yOz4WQZ9yVSScOtMNY3HWYlpEjPcYdIbkSAkxQms5zB4d854TtjjqjBfKjyoXBsMoKEw1Qx5nCb-QbwEzQ2frCfZd_dbBrFN6uVi00ym2xp-ff4MhWvB1sg36fe17__fHWjmO7CjiKB8HUibsxTMLzXBYLJdoSXKr0tRexSEddLZWvRJAkXV8BlU8Sk2nZ5RpeiCfK7yr8AAqQfw0cr4sWJUb1AQ-wg3ObnueL9obdDet5lup109MdK6JecH-mS0DtCxbz86y4jOj-Ga95wQH2b5NblrnSXrnVlsiCTpfJ9QN7N79MlixMFPSlrWX96g75Walfx7RftvahWUJ700mWn40V_RAVphtAQbfLmD-Qk3MKtF6eawdLZ01Agp7kuZ6UwhkWuABcwrlswkF_9oWOnGE0p8MoHtv6229oj27h-ztHJtIMZTFgck5NDZbv4K4pfw0chZZZWHMK-IkfpAo6Tuku8If0Ljm5ErXeI4spKGqFUKmACMoOXoEKJhnisMRjXexyNwZ33iJ-pcNQ2Urq2NDjPDTXgwJOVKVKQtR8aDXfIk79VF5WEvmH_CZuj1oW64CbH7LJaWhhJdQ6aUumIuAhnMUyDhKW-J4CDh-4vkxgqmu4ucIyqbZGs7DH2iIALsq9FnlqJLAWSIrBRqfRrCjCwcdP_yF0NGwIvbBCSQbLoSKb4AHvhDXGGpKrDUlANNUYXkFTqFalCH_bPjxZmcflw0_qYfxTDCBMdTYzMgFWI-yIFrlfWlO9sl4Hs6txRDTsrLH0zZF0fGZKsWNwSuCLB3-f1hq5sXN8sB_uDw73HpKbwLkZ0h-PrZLF6WSmHwGvncrHBkwo-XzV6PUL1FG45w |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamIU28IDYuKwxmEAiQyNYmrp0iIdRtlF3YQLugvoXYsbdKIwlNK1R-GeLXcY7jhAVNwMte65PK8fH5zuf4XAh5wtvSdJNQe4wlPY9pGXvSZ9wTkishwASl7Ty3f8C3T9jusDucIz-rXBgMq6ww0QJ1kin8Rr4OzASdbSDa68aFRXzcGrzJv3rYQQpvWqt2GuUW2dOzb3B8K17vbIGun_r-4O3x5rbnOgx4iofhxEt6CUzI99ssEUp0JLhXGWg_ZrGOe1qqQInQmF6ggNYbY7Mue1zDy3Gjgp7Cj6EA_9dE0O2gjYlhfdgDHOHcpeoForPudsZanqV6zfZ3x-qoF1yh7RhQ-4X5_DwrLiO9f8ZuXnCGg5vkhmOxtF9uu0Uyp9MlsrDv7umXyKKDjII-d3WtX9wiP6qtoBM6KNv80MzQ_mSc5WcjRd_Fhe0MUNCtMv4P5OSMAsWX59rDMlpjkKAnea7HpXCGxS4Ao3AuG3Don36hQ-8wntHDOBm5WtyvaJ9u4vt7RzbqDGUxeHJGbT2W7-C6KX8JfIWWGVkzCliKH6cKOkrpLnCJ9DY5uRK13iHzKShqmVCpgBTKLl6HCiYZYrLEI17S5u0EXHuLBJUOI-WqqmNzj_PIXhUKOF2VKolQ85HTfIt49VN5WVXkH_IbuD1qWawJbn_IxqeRg5hIa9ORTMXASThLZBIaZgJfAZ8P24E0MNVV3FxRmWBbI1vUZx0RAi_lfos8thJYFyRFCzuNp0UR7Xz49B9CR4cNoWdOyGSwHCp2yR7wTlhvrCG50pAEdFON4WU0hWpViug3DsCTlXlcPvyoHsY_xWDCVGdTKxNiZcKuaJG7pTXVK-t3MdMaR0TDzhpL3xxJR2e2LDsGqoSBuPf3aa2SBcCt6P3Owd59ch3oN0Mm5LMVMj8ZT_UDoLgT-dBiCSWfrxq8fgF3er0d |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Associated+factors+of+atrophic+gastritis+diagnosed+by+double-contrast+upper+gastrointestinal+barium+X-ray+radiography%3A+a+cross-sectional+study+analyzing+6%2C901+healthy+subjects+in+Japan&rft.jtitle=PloS+one&rft.au=Yamamichi%2C+Nobutake&rft.au=Hirano%2C+Chigaya&rft.au=Shimamoto%2C+Takeshi&rft.au=Minatsuki%2C+Chihiro&rft.date=2014-10-24&rft.eissn=1932-6203&rft.volume=9&rft.issue=10&rft.spage=e111359&rft_id=info:doi/10.1371%2Fjournal.pone.0111359&rft_id=info%3Apmid%2F25343257&rft.externalDocID=25343257 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |